Match tier
Listed
Presence
Current · Arkansas
Last published
2023
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
Biography and Research Information
Metrics
- h-index: 2
- Publications: 3
- Citations: 46
Selected Publications
-
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer (2023)
Collaboration Network
Top Collaborators
Zhiguo Zhao
Vanderbilt University Medical Center (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Pratik A. Patel
Emory University (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Leonora R. Slatnick
Children's Hospital Colorado (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Anna Sitthi-Amorn
St. Jude Children's Research Hospital (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Kevin Bielamowicz
Arkansas Children's Hospital
1 shared publication
In database
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Alexandra Walsh
Phoenix Children's Hospital (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Jennifer Hess
Phoenix Children's Hospital (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Jenna Rossoff
Northwestern University (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Caitlin W. Elgarten
Children's Hospital of Philadelphia (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Regina M. Myers
Children's Hospital of Philadelphia (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Raya Saab
American University of Beirut Medical Center (LB)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Maya Basbous
American University of Beirut Medical Center (LB)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Meghan McCormick
University of Pittsburgh Medical Center (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Catherine Aftandilian
Stanford University (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Rebecca M. Richards
Stanford University (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer